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In this issue of Chemistry & Biology, Zhang and colleagues developed a yeast cell surface display strategy to
effectively evolve the substrate specificity of DhbE, one of the adenylation domains of the bacillibactin
synthetase complex. The method yields DbhE variants that have dramatically altered substrate specifities
toward unnatural aryl substrates.Nonribosomal peptide synthetases
(NRPSs) are large multimodular enzymes
that are responsible for the biosynthesis
of important bioactive molecules such as
penicillin, cyclosporine, and daptomycin.
NRPSs catalyze the successive formation
of peptide bonds using aminoacyl adeny-
lates. Each module of the NRPS has mini-
mally three domains: the adenylation
domain (A), which specifically activates
an amino acid and transfers it to the thio-
lation domain (T) in an ATP-dependent
fashion; and a condensation domain (C)
that catalyzes the peptide bond formation
between the T domain-tethered amino-
acyl group and the growing peptide
chain. The linear juxtaposition of several
modules constitutes an assembly-line-
like machinery in which the growing
peptide increases in size by one residue
after each module.
This elegantly simple biochemical logic
of NRPSs has made these megasynthe-
tases attractive targets for protein engi-
neering toward production of hybrid prod-
ucts. The A domain, in particular, has
been focused on because of its role in
selection of the individual building blocks.
Classical domain swapping approaches
have led to fruitful combinatorial biosyn-
thesis of analogs as demonstrated in
engineering of the daptomycin synthetase
(Baltz et al., 2005). Directed evolution,
which is an extremely powerful approach
in the engineering of desired traits of
target enzymes, has not been widely
used on natural product biosynthetic
enzymes, largely due to the lack of effec-
tive screening strategies. In this issue of
Chemistry & Biology, Zhang et al. (2013)
developed a yeast cell surface displaystrategy to effectively evolve the sub-
strate specificity of one of the A domains
in the bacillibactin NRPS. They were
able to dramatically alter the A domain
specificity toward unnatural aromatic
building blocks. This approach is gener-
ally applicable to different A domain/
substrate combinations, and may signifi-
cantly increase the repertoire of A
domains that can be used in the construc-
tion of synthetic NRPSs.
An enabling breakthrough for under-
standing and engineering the specificity
of A domains is the first high-resolution
crystal structure of a phenylalanine-
specific A domain (PheA) from the
gramicidin synthetase 1 (Conti et al.,
1997). The crystal structure revealed that
PheA shares a highly conserved domain
arrangement with firefly luciferase, which
is also an adenylating enzyme. PheA
contains a large N-terminal subdomain
and a smaller C-terminal subdomain,
with the active site nestled at the inter-
faces of these two subdomains. Based
on the PheA structural information,
several groups identified the residues
within the A domain binding pocket that
control substrate specificity (Challis
et al., 2000; Stachelhaus et al., 1999).
Structure-guided sequence alignment of
a large number of A domain sequences
in the database led to the assignment of
a ten amino acid (10-aa) code that can
be used to predict A domain substrate
specificity. Moreover, the 10-aa code
has served as a guide in engineering
substrate specificity of adenylation
domains through rational mutagenesis,
as first demonstrated in altering the amino
acid specificity of PheA from L-phenylala-Chemistry & Biology 20, January 24, 20nine to L-leucine (Stachelhaus et al.,
1999). Subsequent examples included
switching the specificity of an A domain
in the surfactin synthetase from L-aspar-
tate to L-asparagine (Eppelmann et al.,
2002) and recently the production of
calcium-dependent antibiotic (CDA)
analogs through mutagenesis of an A
domain in the CDA NRPS (Thirlway
et al., 2012).
Notwithstanding these successes in
modification of A domain specificity, it is
evident that this domain represents an
ideal target for engineering by directed
evolution approaches, such as large scale
saturation mutagenesis at multiple posi-
tions within the 10-aa code. Access to
significantly larger sequence space,
coupled with a high-throughput screening
strategy, should lead to variants that have
dramatically altered substrate specificity.
This is evidenced in the highly successful
engineering of the aminoacyl-tRNA syn-
thetases that control fidelity of the transla-
tion system, which has led to the expan-
sion of the 20 natural amino acid genetic
code (Wang et al., 2001). The first demon-
stration of directed evolution of A domain
was that of the A-T didomain AdmK from
the andrimid pathway. Through saturation
mutagenesis of three residues within the
10-aa code, followed by a product-based
screening of 14,330 clones using liquid
chromatography-tandem mass spec-
trometry, the substrate tolerance of the
A domain was expanded from L-valine
to L-isoleucine, L-leucine, L-alanine, or
L-phenylalanine (Evans et al., 2011).
Whereas this is a significant breakthrough
in NRPS engineering, the use of MS-
based screening is clearly the rate-limiting13 ª2013 Elsevier Ltd All rights reserved 3
Figure 1. Scheme of the Directed Evolution Study of DhbE
(A) DhbE is a stand-alone adenylation domain that activates 2,3-dihydroxybenzoic acid in the biosynthesis of the siderophore bacillibactin. Zhang et al.
(2013) utilized a chemical probe that mimics the acyl-adenylate intermediate of DhbE and screened using fluorescence assisted cell sorting (FACS) to isolate
desired mutants.
(B) Crystal structure of DhbE (accession number 1MDB) showing the sites targeted for saturation mutagenesis by Zhang et al. (2013) for the directed
evolution study.
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Toward developing a high throughput
screening method for engineering the A
domain, Zhang et al. (2013) employed
a yeast-surface displayed method that
has been successfully used in the evolu-
tion of a wide range of polypeptides,
such as antibody fragments (Boder and
Wittrup, 1997). Their target was the stand-
alone DhbE A domain, which is part of the
NRPS machinery for biosynthesis of
the siderophore bacillibactin in Bacillus
subtilis. The goal is to expand the sub-
strate specificity of DhbE from the natural
2,3-dihydroxybenzoic acid (DHB). To
display DhbE and generated mutants,
wild-type DhbE was first genetically fused
to Aga2p, which allows the transport and
adhesion of the fusion protein to the yeast
cell surface. Furthermore, DhbE was
fused to an N terminus HA tag and a C
terminus myc tag, which can be recog-
nized by anti-HA and anti-myc antibodies,
respectively. This enabled the use of fluo-
rescence assisted cell sorting (FACS) with
a flow cytometer to capture the yeast cells
displaying full-length DhbE.
In order to capture DhbE fusion
proteins that can bind to the desired
substrate or acyl-adenylate, probes con-4 Chemistry & Biology 20, January 24, 2013 ªsisting of an acyl-adenosyl-monosulfa-
mate (acyl-AMS) covalently linked to
biotin were synthesized. The acyl-AMS
moiety is a nonhydrolyzable mimic of the
acyl-AMP intermediate that acts as a
‘‘bait’’ to bind DhbE, while the biotin
moiety allowsconjugation toafluorophore
tethered to streptavidin. Therefore, in this
design, cells displaying DhbE, as shown
by binding of fluorescent anti-myc anti-
body, and those that bind to the acyl-
AMS probe, as shown by conjugation of
the fluorescent streptavidin probe, can
be captured through FACS (Figure 1A).
To prove that the acyl-AMS based probe
can bind to DhbE, a salicylyl-AMS probe,
in lieu of the redox sensitive DHB, was
synthesized and was shown to select for
the cells that display DhbE. Two other
chemical probes that contain 3-hydroxy-
benzoate (3-HBA) and anthranilate (2-
ABA) were also synthesized and were
subsequently used for the FACS-based
selection of mutants. The chemical probe
design also allows one to screen a variety
of unnatural substrates by simply chang-
ing the acyl-AMS portion of the probe to
the targeted acyl group.
Based on the X-ray crystal structure of
DhbE (May et al., 2002) and the 10-aa
code, four residues (His234, Asn235,2013 Elsevier Ltd All rights reservedAla333, and Val337) were chosen for satu-
ration mutagenesis (Figure 1B). Asn235
and Val337 were part of the 10-aa code,
while His234 and Ala333 were shown to
be in proximity of the binding pocket.
The synthesized acyl-AMS of 3-HBA and
2-ABA were then incubated with DhbE
mutants displayed on yeast surface.
Thereafter, streptavidin bound to phyco-
erythrin was incubatedwith the yeast cells
to capture the DhbEmutants that bind the
acyl-AMS probes. Using FACS to screen
through 5 3 106 colonies, the authors
were able to isolate a DhbE mutant (KZ4)
that has an 11-fold higher kcat/KM
compared to wild-type DhbE toward 3-
HBA and 3-fold lower kcat/KM compared
to wild-type DhbE toward DHB, thus
switching its selectivity 30-fold. On the
other hand, the KZ12 mutant has a 6.2-
fold higher kcat/KM compared to wild-
type DhbE toward 2-ABA, and an 11-
fold lower kcat/KM compared to wild-type
DhbE toward DHB, which accounts for
a dramatic 206-fold switch in selectivity
toward 2-ABA. Thus, Zhang et al. (2013)
were able to prove that yeast cell surface
display coupled with FACS is an effective
high-throughput screeningmethod for the
directed evolution of NRPS A domains.
This method can be extended to any
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the preparation of the corresponding
acyl-AMS probe. The next challenge
would be to further evolve the rest of the
NRPS assembly line to process the unnat-
ural building block efficiently.
The marriage of directed evolution and
natural product biosynthesis is a tanta-
lizing union toward production of ‘‘unnat-
ural’’ natural products. The difficulties
associated with high throughput screen-
ing of desired phenotypes have severely
limited progresses in this regard. Zhang
et al. (2013) demonstrated that powerful
techniques, such as yeast surface
display, which are widely used in the
protein engineering field, can be effec-
tively designed to allow rapid screening
of enzymes in secondary metabolism.This important work has only scratched
the surface. It is anticipated that addi-
tional ingenious approaches can signifi-
cantly improve our abilities to tailor the
properties of these enzymes toward
customized synthesis of target small
molecules.REFERENCES
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Small molecule inhibitors of amyloid aggregation have potential as treatment for a variety of conditions. In
this issue of Chemistry & Biology, Romero and colleagues use amyloid-dependent B. subtilis biofilm
formation to screen for amyloid inhibitors, identifying compounds that not only inhibit B. subtilis biofilm
formation but also ones that disrupt preformed biofilms.Amyloid fibers are historically associated
with diseases such as Alzheimer’s, Hun-
tington, and the prion diseases. Many
proteins can adopt the amyloid confor-
mation—essentially a b-rich repeating
structure where the b strands orient
perpendicular to the fiber axis. Ordered
amyloid protein polymers upset cellular
proteostasis because they can inappro-
priately interact with membranes or
sequester chaperone machinery. There-
fore, the search is on for ways to amelio-
rate amyloid-related diseases by targeting
amyloid formation. A major hurdle in
this endeavor is that disease-associated
amyloid formation is sporadic and difficult
to faithfully reproduce inmodel organisms.However, a growing number of ‘‘func-
tional’’ amyloids have been identified that
are assembled by dedicated biogenesis
systems. Functional amyloids and their
assembly systems have been found in
nearly all walks of cellular life, including
mammals, fungi, and bacteria (Hammer
et al., 2008, Fowler et al., 2007). Functional
amyloids contribute to cellular biology
in various ways, including regulation of
melanin synthesis, information transfer,
or as a structural component. Further-
more, some of these functional amyloid
systems provide a unique platform for
understanding how amyloid formation
can be directed and controlled so that
cellular toxicity is minimized.Amyloids are commonly found as
the major protein component of the
extracellular matrix in bacterial biofilms.
Bacteria within the biofilm are protected
from environmental insults, including
disinfectants and antibiotics, making
biofilms a major concern in hospital
and industrial settings. Therefore, factors
that can disrupt bacterial amyloid
formation would be potential lead
compounds for targeting bacterial bio-
films or amyloid formation in general.
The study presented in this issue of
Chemistry & Biology by Romero et al.
(2013) describes Bacillus subtilis pellicle
biofilm as a model system to screen
for amyloid inhibitors. The extracellular13 ª2013 Elsevier Ltd All rights reserved 5
